Business & Regulation

Pharma companies are well accustomed to supply chain issues, but how prepared are they for issues impacting access to medical devices?

Celebrate a decade of pharma innovation with The Medicine Maker’s top features, from cancer vaccines to CRISPR breakthroughs.

Summarizing the updated lessons learned by the European Medicines Agency following the COVID-19 pandemic.

As 2024 draws to its conclusion, two experts look at trends in clinical trials and form predictions for 2025.

AI, the Inflation Reduction Act, and a surge in precision medicine; experts look at pharma’s future.

AI solutions can help sift through clinical trial data for effective medical writing, but more people need to use it.

Experts share their insights on the disruptive trends reshaping healthcare, including the rise of personalized medicine and digital innovation.

Alcami experts discuss what’s needed to accelerate drug development.

EU-based associations voice concerns over joint clinical assessments and the lack of advice meetings.

From wearable health tech to telehealth, here’s how digital transformation could impact the pharma industry and patient access.